Cerebral Palsy News

Multaq Lawsuit : Chronic Hepatitis B and Long-term Liver Cancer Risk

People with chronic hepatitis B are at increased risk for developing liver cancer. The exact risk is unknown, but in some studies, people with chronic hepatitis B were two hundred times more likely to develop liver cancer compared with people without this disease. Cancer usually occurs in those who have developed cirrhosis. However, cancer can also occur in chronic HBV carriers without cir­rhosis. In fact, in some parts of the world where hepatitis B is endemic, such as in Africa, up to 30 percent of people with chronic hepatitis B develop liver can­cer without underlying cirrhosis.

Prom the time a person becomes infected with HBV, liver cancer generally takes about twenty to thirty years to develop. Thus, people who were infected at birth can develop liver cancer as early as the age of twenty. It appears that infec­tion with both HBV and HCV or infection with both HBV and HDV, drinking ex­cessive alcohol, and having a family history of HCC can increase the likelihood that a person will develop liver cancer. It has been noted that men appear to have an increased risk ot developing HCC compared to women. Whether this is due to hormonal differences is unclear. See chapter 19 for more information on HBV and liver cancer.

More information on Multaq Lawsuit

THE HEPATITIS DELTA VIRUS (HDV)

Hepatitis D is inflammation of the liver due to a virus called the hepatitis delta virus (HDV). HDV is a virus that can live only in people with hepatitis B. Ap­proximately 70,000 people in the United States are infected with HDV. Although HDV only accounts for a small percentage of cases of chronic viral hepatitis, it tends to be particularly severe and to have significant long-term consequences. In fact, chronic hepatitis D causes more than one thousand deaths each year in the United States. In the 1970s, hepatitis delta virus infection was endemic through­out Southern Europe. However, by the 1990s the incidence of HDV infection had significantly decreased. In fact, one study done in Italy estimated that the num­ber of cases of HDV within that country decreased by 1.5 percent each year from 1987 to 1997. And, it is anticipated that this trend will continue. Currently, new HDV infections are rare.

Information from other sources on Multaq Lawsuit

HDV infection may be silent or may cause the same kind of fatigue and other symptoms associated with other forms of hepatitis. However, up to 20 percent of hepatitis D patients develop fulminant hepatitis, a particularly serious condition that requires hospitalization. See chapter 7 for a discussion on fulminant hepatitis.

HDV is transmitted through the same blood, sexual, and perinatal routes as HBV, which were discussed on page 92. There are two ways in which a person infected with HBV may become infected with HDV: coinfection and superinfection. When HBV and HDV are acquired at the same time, it is known as coinfection. In 90 to 95 percent of cases, such people will be able to completely eliminate both viruses from their bodies. This means that only approximately 5 to 10 percent of coinfected individuals go on to develop chronic hepatitis B and D. HDV can also be acquired by someone who already has chronic hepatitis B. This is known as superinfection. In contrast to people infected with both viruses simultaneously, approximately 70 to 95 percent of people who become infected in this two-step fashion progress to chronic hepatitis D.

Our use of the term or terms Multaq Lawsuit is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Multaq Lawsuit visit our site often.

http://www.seedol.com

Multaq Lawsuit : Virtually everyone knows that the liver is an organ essential to life, but most people do not really know what it does. Many will say that the liver plays some role in “purifying,” or “cleansing,” the blood. Some will know that it is the site of metabolism for many different drugs. Oth”ers will know that the liver is involved in the formation of bile.

The liver has many different functions, indeed. A thorough under”standing of the three critical aspects of normal liver structure and func”tion is essential to understanding what has gone wrong in a diseased liver. The first critical aspect is the liver’s overall anatomy and, in par”ticular, its blood supply. The second aspect is the synthetic biochemi”cal functioning of the hepatocytes, the predominant cells in the liver. The third critical aspect is the central role of the liver in the metabo”lism and secretion of bilirubin.

More information on Multaq Lawsuit

The liver is located in the right upper quadrant of the abdomen (Fig”ure 1.1). If you place your fingers under your rib cage on the right side, you should be able to feel the edge of your liver when you take a deep breath. The liver itself is divided into the right and left lobes.

A portion of the right lobe is subdivided into the caudate and quadrate lobes. Various ligaments separate the lobes from each other. Most of the liver’s mass is found in the right lobe. Most of the liver’s surface is cov”ered by a capsule that contains nerves that can sense pain. The gall”bladder is located under the liver.

Information from other sources on Multaq Lawsuit

Because of this, the liver is the first organ to gain nutrients, drugs, and toxins that are absorbed from the stomach and intestine. Consequently, the liver plays a primary role in the metabolism of these nutrients, drugs, and toxins. The portal vein also connects with the splenic vein, which drains the spleen. This connection is important because if the blood flow to, within, or exiting the liver is impeded for any reason, it will back up into the spleen.

The liver also receives blood from the hepatic artery. This blood reaches the liver directly from the heart after passing through the lungs and is higher in oxygen content than the blood in the portal vein. When entering the liver, the blood from the portal vein and hepatic artery mix. This dual blood supply to the liver makes the probability of suf”fering an infarction (or death of tissue due to loss of blood supply from a clot as occurs in the heart during a myocardial infarction, or heart attack) low.

Our use of the term or terms Multaq Lawsuit is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Multaq Lawsuit visit our site often.

http://www.seedol.com